SCR-LIP-000160 · Claim · machine-readable JSON →

In a 60-patient single-centre prospective cohort with stage I-II lipedema, tumescent liposuction produced large symptom improvements (effect sizes d=1.04-2.18 for spontaneous pain, pressure sensitivity, edema, bruising, movement restriction, cosmetic impairment and quality of life) that persisted at 12 years post-operatively with no clinically relevant deterioration, and 27% of patients no longer required any conservative therapy.

Emerging clinical association Evidence certainty: moderate (GRADE)

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

2020Improvements in patients with lipedema 4, 8 and 12 years after liposuction — Baumgartner et al. (2020) · supporting

Evidence (1)

Context (PECO)

Conditionlipedema
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log